Detalhe da pesquisa
1.
Spatial predictors of immunotherapy response in triple-negative breast cancer.
Nature
; 621(7980): 868-876, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37674077
2.
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial.
Lancet
; 401(10371): 105-117, 2023 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495879
3.
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.
Lancet
; 401(10390): 1773-1785, 2023 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086745
4.
Real-world use of multigene signatures in early breast cancer: differences to clinical trials.
Breast Cancer Res Treat
; 205(1): 39-48, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265569
5.
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy.
Br J Cancer
; 129(12): 2025-2033, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935787
6.
Design of SERENA-6, a phase III switching trial of camizestrant in ESR1-mutant breast cancer during first-line treatment.
Future Oncol
; 19(8): 559-573, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37070653
7.
ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer.
Future Oncol
; 18(32): 3563-3572, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36382554
8.
Primary Founder Mutations in the PRKDC Gene Increase Tumor Mutation Load in Colorectal Cancer.
Int J Mol Sci
; 23(2)2022 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35054819
9.
Personalized Risk-Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak.
Oncologist
; 25(7): e1013-e1020, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32412693
10.
Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer.
Breast Cancer Res Treat
; 167(1): 39-47, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28905250
11.
Dissecting Time- from Tumor-Related Gene Expression Variability in Bilateral Breast Cancer.
Int J Mol Sci
; 19(1)2018 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29315233
12.
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer.
Breast Cancer Res
; 19(1): 16, 2017 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28183321
13.
Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients.
Cancer Sci
; 107(12): 1730-1735, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27727484
14.
Assessing cost-utility of predictive biomarkers in oncology: a streamlined approach.
Breast Cancer Res Treat
; 155(2): 223-34, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26749360
15.
The immune system and response to HER2-targeted treatment in breast cancer.
Lancet Oncol
; 15(2): e58-68, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24480556
16.
Prognostic significance of a signature based on senescence-related genes in colorectal cancer.
Geroscience
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658505
17.
Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug conjugates (ADCs).
Cancer Treat Rev
; 123: 102672, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38118302
18.
Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer.
Cancer Treat Rev
; 128: 102762, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38776613
19.
Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice.
Front Oncol
; 14: 1374547, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38529378
20.
PARP Inhibitors for Breast Cancer Treatment: A Review.
JAMA Oncol
; 10(5): 658-670, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512229